GB0021668D0 - New use - Google Patents

New use

Info

Publication number
GB0021668D0
GB0021668D0 GBGB0021668.9A GB0021668A GB0021668D0 GB 0021668 D0 GB0021668 D0 GB 0021668D0 GB 0021668 A GB0021668 A GB 0021668A GB 0021668 D0 GB0021668 D0 GB 0021668D0
Authority
GB
United Kingdom
Prior art keywords
new use
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0021668.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB0021668.9A priority Critical patent/GB0021668D0/en
Publication of GB0021668D0 publication Critical patent/GB0021668D0/en
Priority to AU1046702A priority patent/AU1046702A/en
Priority to PCT/EP2001/009923 priority patent/WO2002020609A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5431—IL-11
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
GBGB0021668.9A 2000-09-04 2000-09-04 New use Ceased GB0021668D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0021668.9A GB0021668D0 (en) 2000-09-04 2000-09-04 New use
AU1046702A AU1046702A (en) 2000-09-04 2001-08-27 New use
PCT/EP2001/009923 WO2002020609A2 (en) 2000-09-04 2001-08-27 Interleukin-11 for the treatment of stroke and neuropathies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0021668.9A GB0021668D0 (en) 2000-09-04 2000-09-04 New use

Publications (1)

Publication Number Publication Date
GB0021668D0 true GB0021668D0 (en) 2000-10-18

Family

ID=9898797

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0021668.9A Ceased GB0021668D0 (en) 2000-09-04 2000-09-04 New use

Country Status (3)

Country Link
AU (1) AU1046702A (en)
GB (1) GB0021668D0 (en)
WO (1) WO2002020609A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201522186D0 (en) 2015-12-16 2016-01-27 Singapore Health Services Pte Ltd And Nat University Of Singapore The Treatment of fibrosis
GB201621439D0 (en) 2016-12-16 2017-02-01 Singapore Health Services Pte Ltd And Nat Univ Of Singapore IL-11Ra Antibodies
MX2019007020A (en) 2016-12-16 2019-10-21 Singapore Health Serv Pte Ltd Il-11 antibodies.
CA3126322A1 (en) 2019-01-21 2020-07-30 Singapore Health Services Pte. Ltd. Treatment of hepatotoxicity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08176008A (en) * 1994-12-27 1996-07-09 Toray Ind Inc Neurotrophic agent
US5679339A (en) * 1995-06-27 1997-10-21 Keith; James Method of using IL-11 for treating spondyloarthropies
JP2003507349A (en) * 1999-08-18 2003-02-25 ザ ゼネラル ホスピタル コーポレーション Methods, compositions and kits that facilitate recovery from damage to the central nervous system

Also Published As

Publication number Publication date
WO2002020609A3 (en) 2002-07-04
AU1046702A (en) 2002-03-22
WO2002020609A2 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
PL357210A1 (en) Novel use
GB0021885D0 (en) New use
GB0021303D0 (en) Use
GB0025788D0 (en) Use
HK1052462A1 (en) Gm-negative ehv-mutants
GB0006864D0 (en) New use
GB0005070D0 (en) Use
GB0021668D0 (en) New use
GB0004183D0 (en) New use
GB0029634D0 (en) Use
GB0018248D0 (en) New use
GB0027783D0 (en) Novel use
GB0027181D0 (en) New use
GB0015869D0 (en) New use
GB0026230D0 (en) New use
GB0002398D0 (en) New use
GB0005219D0 (en) New use
GB0016360D0 (en) New use
GB0029411D0 (en) New use
GB0001445D0 (en) New use
GB0006578D0 (en) New use
GB0022572D0 (en) New use
GB0011799D0 (en) Use
GB0014193D0 (en) Use
GB0002113D0 (en) Use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)